News | August 30, 2021
Acute therapies drive overall pharma growth in July: Ind-Ra
The segment delivered strong sales growth of 20% YoY
The segment delivered strong sales growth of 20% YoY
The notification implies that any export of Rapid Antigen Kit will require a licence or permission from DGFT
It leverages Kite’s Chimeric Antigen Receptors and Appia Bio’s Allogeneic Cell Technology Platform to Develop Off-the-Shelf Cell Therapies
The govt has rolled out three schemes for promoting the manufacture of API
Robust demand for the product across the Middle East, Africa and Latin America
Turnover of API division of ISLL stood at Rs 856.58 crore
The expanded laboratories and manufacturing facilities at Nansha are expected to come online between Q1 2022 and Q3 2022
Posaconazole is a triazole antifungal agent indicated for treating mucormycosis patients
Much-needed diagnostics supplies will help accelerate testing capabilities of hospitals and clinics across India
They stressed that while the drug is clinically proven to support weight and blood sugar control, it must be prescribed only after careful patient evaluation and used under strict medical supervision.
Subscribe To Our Newsletter & Stay Updated
